V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013214 | 160012150 | 1.76 | 79.1 | Palliative (P) | 2019-07-19 | 2019-07-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100457641 |
| 160013215 | 160012151 | 1.85 | 87 | Palliative (P) | 2021-01-15 | 2021-04-30 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100845242 |
| 160013216 | 160012152 | 1.65 | 62.15 | null | 2018-08-11 | 2018-08-19 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100940128 |
| 160013217 | 160012153 | 1.73 | 87.7 | Palliative (P) | 2018-03-13 | 2018-03-20 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100744196 |
| 160013220 | 160012154 | 1.6 | 108 | Palliative (P) | null | null | NIVOLUMAB | 02 | N | NIVOLUMAB | 101281478 |
| 160013224 | 160012155 | 1.61 | 86.8 | null | 2017-11-03 | 2017-11-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100688571 |
| 160013230 | 160012156 | 1.5 | 57.4 | Palliative (P) | 2017-04-16 | 2017-06-15 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100316109 |
| 160013232 | 160012157 | 1.74 | 117.5 | null | 2020-08-24 | 2020-09-08 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101299036 |
| 160013235 | 160012158 | 1.67 | 77.7 | null | 2018-02-28 | 2018-03-01 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101000259 |
| 160013238 | 160012159 | null | 56.9 | Palliative (P) | 2021-10-15 | 2021-10-19 | Trabectedin | 02 | N | TRABECTEDIN | 101706243 |
| 160013243 | 160012160 | 1.64 | 59 | Palliative (P) | 2017-11-08 | 2017-11-14 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101768854 |
| 160013244 | 160012161 | 1.57 | 85 | Palliative (P) | 2018-12-05 | 2018-12-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101799097 |
| 160013245 | 160012162 | 1.82 | 79.5 | Palliative (P) | 2022-01-24 | 2022-01-25 | Doxorubin 50mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100934321 |
| 160013247 | 160012163 | 1.77 | null | Palliative (P) | 2021-08-06 | 2021-08-22 | VINORELBINE | 02 | N | VINORELBINE | 100827806 |
| 160013248 | 160012164 | 1.75 | 90.9 | Palliative (P) | 2020-04-13 | 2020-04-20 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100579368 |
| 160013249 | 160012165 | 1.73 | 75.4 | Palliative (P) | 2019-12-16 | 2019-12-22 | Vinorelbine (weekly iv) | 02 | null | VINORELBINE | 101588170 |
| 160013250 | 160012166 | 1.86 | 64 | null | 2021-01-10 | 2021-01-10 | Trabectedin | 02 | null | TRABECTEDIN | 100251324 |
| 160013254 | 160012167 | 1.59 | 89.6 | Palliative (P) | 2020-12-31 | 2021-01-19 | VINORELBINE | 02 | N | VINORELBINE | 101065153 |
| 160013255 | 160012168 | 1.72 | 61.2 | Palliative (P) | 2018-12-03 | 2018-12-03 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101240133 |
| 160013256 | 160012169 | 1.73 | 60.5 | Palliative (P) | 2019-01-23 | 2019-02-09 | DOXORUBICIN | 02 | N | VINORELBINE | 101670964 |
| 160013259 | 160012170 | 1.53 | 78 | Palliative (P) | 2020-08-11 | 2020-08-11 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100750835 |
| 160013261 | 160012171 | 1.61 | 0 | null | 2019-06-30 | 2019-07-10 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 100678453 |
| 160013266 | 160012172 | 1.63 | 117.5 | null | 2018-02-12 | 2018-02-12 | VINORELBINE | N | null | VINORELBINE | 100994507 |
| 160013268 | 160012173 | 0 | 53.7 | Palliative (P) | 2018-10-07 | 2018-10-07 | DOXORUBICIN | 02 | N | VINORELBINE | 101515380 |
| 160013269 | 160012174 | 1.62 | null | Palliative (P) | 2018-05-13 | 2018-05-19 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101807407 |
| 160013270 | 160012175 | 1.72 | 63 | null | 2020-03-27 | 2020-04-07 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101462330 |
| 160013271 | 160012176 | 1.82 | 72.8 | null | 2017-08-06 | 2017-08-10 | Trabectedin | 02 | null | TRABECTEDIN | 101117579 |
| 160013272 | 160012177 | 0 | 88.8 | Palliative (P) | 2021-02-01 | 2021-02-04 | VINORELBINE | null | N | VINORELBINE | 100212241 |
| 160013276 | 160012178 | 1.82 | 81 | null | 2016-08-12 | 2016-08-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101588323 |
| 160013278 | 160012179 | 0 | 87.3 | Palliative (P) | 2016-12-08 | 2017-03-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101068961 |
| 160013280 | 160012180 | 1.62 | 66.3 | Palliative (P) | 2017-03-17 | 2017-04-03 | VINORELBINE | 02 | N | VINORELBINE | 100811131 |
| 160013281 | 160012181 | 1.82 | 74.95 | null | 2020-04-05 | 2020-04-11 | DOXORUBICIN | 02 | null | TRABECTEDIN | 100472229 |
| 160013285 | 160012182 | 1.6 | 59.6 | Palliative (P) | 2019-06-20 | 2019-06-22 | DOXORUBICIN | 02 | N | TRABECTEDIN | 101219911 |
| 160013287 | 160012183 | 1.81 | 96.1 | Neo-adjuvant (N) | 2020-04-19 | 2020-05-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101247750 |
| 160013293 | 160012184 | 1.81 | 83.5 | null | 2018-03-05 | 2018-10-02 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100545890 |
| 160013294 | 160012185 | 1.81 | 74.65 | Palliative (P) | 2017-08-30 | 2017-09-06 | DOXORUBICIN | 02 | N | NIVOLUMAB | 100675949 |
| 160013296 | 160012186 | 1.54 | 81.5 | Palliative (P) | 2018-11-15 | 2019-01-24 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100079234 |
| 160013297 | 160012187 | 1.86 | 92.4 | null | 2017-10-22 | 2017-10-22 | Doxorubicin 75mg/m2 | null | null | VINORELBINE | 101126733 |
| 160013301 | 160012188 | 1.73 | 94.8 | Palliative (P) | 2019-02-23 | 2019-03-03 | Doxorubicin 75mg/m2 | N | N | TRIAL UNSPECIFIED | 101445911 |
| 160013303 | 160012189 | 1.59 | 76.5 | Palliative (P) | 2019-10-09 | 2019-10-20 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100277779 |
| 160013309 | 160012190 | 1.64 | 79.9 | Palliative (P) | 2020-04-06 | 2020-04-08 | Doxorubicin 75mg/m2 | N | N | TRIAL UNSPECIFIED | 100370378 |
| 160013312 | 160012191 | 1.67 | 74.1 | Palliative (P) | 2021-03-04 | 2021-09-24 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100871955 |
| 160013316 | 160012192 | 1.59 | null | null | 2018-08-04 | 2018-08-06 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 101205907 |
| 160013318 | 160012193 | 1.74 | 69.6 | Palliative (P) | 2019-11-28 | 2020-01-09 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100555808 |
| 160013319 | 160012194 | 1.52 | 116 | null | 2017-10-18 | 2017-10-19 | Vinorelbine (oral) | N | null | VINORELBINE | 100011307 |
| 160013320 | 160012195 | 1.6 | 50.8 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-21 | DOXORUBICIN | N | N | DOXORUBICIN | 101426540 |
| 160013322 | 160012196 | 1.88 | 71.3 | null | 2017-02-18 | 2017-03-01 | DOXORUBICIN | null | null | DOXORUBICIN | 100926441 |
| 160013326 | 160012197 | 1.68 | 70.4 | Palliative (P) | 2018-10-05 | 2018-10-19 | VINORELBINE | 02 | N | VINORELBINE | 100760545 |
| 160013329 | 160012198 | 1.72 | 82 | Palliative (P) | 2019-03-20 | 2019-03-29 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101863052 |
| 160013332 | 160012199 | 1.79 | 105 | Palliative (P) | 2020-07-25 | 2020-08-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100642119 |